A comparison of non-integrating reprogramming methods-Reference-Cited by-同舟云学术

A comparison of non-integrating reprogramming methods

Published:2014-12-01 Issue:1 Volume:33 Page:58-63
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Schlaeger Thorsten M,Daheron Laurence,Brickler Thomas R,Entwisle Samuel,Chan Karrie,Cianci Amelia,DeVine Alexander,Ettenger Andrew^ORCID,Fitzgerald Kelly,Godfrey Michelle,Gupta Dipti,McPherson Jade,Malwadkar Prerana,Gupta Manav,Bell Blair,Doi Akiko,Jung Namyoung,Li Xin,Lynes Maureen S,Brookes Emily,Cherry Anne B C,Demirbas Didem,Tsankov Alexander M,Zon Leonard I,Rubin Lee L,Feinberg Andrew P,Meissner Alexander,Cowan Chad A,Daley George Q

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.3070.pdf

Reference40 articles.

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).

3. Park, I.H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).

4. Fusaki, N. et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 85, 348–362 (2009).

5. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409–412 (2011).

Cited by 426 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of organoid platform in cardiovascular research;Bioactive Materials;2024-10

2. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis;Expert Opinion on Biological Therapy;2024-08-23

3. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine;BioEssays;2024-06-25

4. TSC2loss in neural progenitor cells suppresses translation of ASD/NDD-associated transcripts in an mTORC1- and MNK1/2-reversible fashion;2024-06-04

5. Evaluation of the impact of iPSC differentiation protocols on transcriptomic signatures;Toxicology in Vitro;2024-06